Atlas Trials

Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea

Clinical trial NCT02160223 · COMPLETED

Trial details

NCT number
NCT02160223
Sponsor
Diskapi Teaching and Research Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Obstructive Sleep Apnea
Start date
2012-01-01
Primary completion
2014-06-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.